Indications
Torsades de pointes. Severe bronchoconstriction with impending respiratory failure. Seizure in the third trimester of pregnancy or postpartum. Seizure prevention in severe pre-eclampsia.
Contraindications
Hypersensitivity, myocardial damage, diabetic coma, heart block, hypermagnesemia, hypercalcemia.
Adult dose
Torsades with a pulse: 1-2 g IV over 10 minutes.
Torsades in cardiac arrest: 2 g IV over 1-2 minutes.
Severe bronchoconstriction with impending respiratory failure: 40 mg/kg IV (max 2 g) over 10-15 minutes. Consider a lower dose of 1 g IV for geriatric patients.
Pre-eclampsia seizure prevention (pregnancy over 20 weeks): 4 g IV over 20-30 minutes, then 2 g/hr IV if available. With severe hypertension: 4 g IV over 5-10 min, then 2 g/hr.
Eclamptic seizure: 6 g IV over 5-10 minutes, or 8 g IM (4 g in each buttock).
Pediatric dose
Torsades in cardiac arrest: 25-50 mg/kg.
Severe bronchoconstriction with impending respiratory failure (age 2 and older): 40 mg/kg IV (max 2 g) over 10-15 minutes.
Route
IV, IO, IM (eclampsia)
Special considerations
Watch for toxicity. It tends to progress in order: hypotension, then loss of deep tendon reflexes, then somnolence and slurred speech, then respiratory paralysis, then cardiac arrest. Check reflexes after you give it, since losing them comes early in that list.
For toxicity: stop the drip, support breathing, and give calcium gluconate 3 g IV or calcium chloride 1 g IV if respiratory arrest is pending.
It can cause hypotension. That usually responds to a fluid bolus.
Do not give it inhaled for bronchospasm. In VF or pulseless VT, routine use is not recommended unless it's refractory, or the rhythm is polymorphic VT or torsades.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Tachycardia with a Pulse; Cardiac Arrest (VF/VT/Asystole/PEA); Respiratory Distress (Includes Bronchospasm, Pulmonary Edema); Eclampsia/Pre-Eclampsia; Seizures; Purpose and Notes. Levels from the National EMS Scope of Practice Model (2019).